跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,372 条关于
“Alar Pharmaceuticals”
全部
9,372
临床试验
943
药物
1,767
机构
2,048
资讯
4,614
18天前
FDA Issues Untitled Letter to Alar Pharmaceuticals Over Promotion of Unapproved Ketamine Drug ALA-3000
5个月前
Alar Pharmaceuticals Reports Breakthrough Phase 1 Results for Long-Acting Ketamine Injectable ALA-3000 in Treatment-Resistant Depression
去年
HanAll, Daewoong, and NurrOn Announce Positive Phase 1 Results for Parkinson's Disease Therapy HL192 (ATH-399A)
去年
Bora Pharmaceuticals Acquires Pyros Pharmaceuticals, Expanding Rare Disease Portfolio
去年
MIRA Pharmaceuticals to Acquire SKNY Pharmaceuticals, Expanding into $200 Billion Weight Loss and Smoking Cessation Markets
去年
ARIAD Pharmaceuticals Accelerates Ponatinib to Market
去年
OnKure Therapeutics Advances Mutant-Specific PI3Kα Inhibitor OKI-219 Following Merger
去年
Quoin Pharmaceuticals Expands Netherton Syndrome Clinical Trials to the UK
去年
Lipigon Pharmaceuticals Appoints Johan Liwing as New CEO
9年前
Actinium Pharmaceuticals' Actimab-A Receives Orphan Designation in the EU for AML Treatment
第 1 页,共 462 页
上一页
下一页